NR1H4 and metabolic dysfunction-associated steatotic liver disease: A recent study by Nian et al. (2023) demonstrated that the combination of Akkermansia muciniphila and Bifidobacterium bifidum protected against the development of non-alcoholic fatty liver disease (NAFLD) in mice by regulating the expression of FXR and the intestinal microbiota.